Onasemnogene abeparvovec for treating spinal muscular atrophy type 1 [ID1473]: evaluation consultation
We are listening to your views on this highly specialised technology. Comments close 06 April 2021.
We are listening to your views on this highly specialised technology. Comments close 06 April 2021.